Same Indication

Muromonab-Cd3 vs Trastuzumab

Muromonab-Cd3 vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Muromonab-Cd3 and Trastuzumab.

Mechanism of Action

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Trastuzumab β€” 28 days.

Chemical Properties

Type: Muromonab-Cd3 β€” Unknown; Trastuzumab β€” Antibody.